tirzepatide and sinus problems A newly published case series reports that GLP-1 receptor agonists (like Tirzepatide | C225H348N48O68 | CID
Description
Not a rebound
BMI 30, or 27 with weight-related health factors
Decreased appetite, fatigue, and headaches are also common
When drugs are in shortage, they can be compounded in larger quantities to help fill the gap
Nausea, diarrhea, and digestive discomfort occur roughly 5% to 10% more often with tirzepatide
